Is There NO Treatment For Severe Sepsis?

Area of Science:

• Critical Care Medicine
• Immunology
• Pharmacology

Background:

• Sepsis is a life-threatening systemic inflammatory response to infection, potentially leading to severe sepsis, organ failure, and septic shock.
• Current clinical management relies on supportive measures, with limited success from controversial treatments like low-dose corticosteroids or recombinant human activated protein C.

Purpose of the Study:

• To review the current landscape of sepsis treatment, highlighting the unmet need for effective mediator-directed therapies.
• To evaluate past and potential future therapeutic targets in severe sepsis and septic shock.

Main Methods:

• Review of existing literature on sepsis pathophysiology and treatment strategies.
• Analysis of the efficacy and limitations of various therapeutic approaches, including immunomodulators and pathway inhibitors.

Main Results:

• Despite numerous attempts, no specific mediator-directed treatment for sepsis has proven consistently effective.
• Approaches targeting lipopolysaccharide (LPS), tumor necrosis factor (TNF), and interleukin-1 (IL-1) failed.
• Inhibiting nitric oxide synthases showed promise but faced challenges; downstream targets like soluble guanylate cyclase are potential alternatives.

Conclusions:

• Effective, specific treatments for sepsis remain elusive, underscoring the need for innovative therapeutic development.
• Targeting downstream effectors of nitric oxide may offer a more viable therapeutic avenue for sepsis and septic shock.